Overview

AFTER: Altering Fat Through Estrogen and Raloxifene

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether estrogens specifically promote a reduction in fat from abdominal regions during weight loss and/or prevent the accumulation of abdominal fat during weight gain.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Aging (NIA)
Treatments:
Estrogens
Estrogens, Conjugated (USP)
Raloxifene Hydrochloride